1st Quarter - Report
HOSPIRA, INC. for HOSPIRA INC
Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
The Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act relating to delay of the ACA medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
| WENDY SUSSMAN | — |
Health Issues HCR
Issues related to drug approvals at the FDA including biosimilars; issues related to drug shortages; issues related to heroin and opioid overdose.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
| WENDY SUSSMAN | — |
Pharmacy PHA
Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
| WENDY SUSSMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.